Renal Function after Radioligand Treatment with 177Lu-PSMA-617

被引:0
作者
Ngoc, Christina Nguyen [1 ]
Happel, Christian [1 ]
Davis, Karen [1 ]
Groener, Daniel [1 ]
Mader, Nicolai [1 ]
Mandel, Philipp [2 ]
Tselis, Nikolaos [3 ]
Gruenwald, Frank [1 ]
Sabet, Amir [1 ]
机构
[1] Univ Hosp Frankfurt, Nucl Med, Frankfurt, Germany
[2] Univ Hosp Frankfurt, Urol, Frankfurt, Germany
[3] Univ Hosp Frankfurt, Radiooncol, Frankfurt, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1279
引用
收藏
页数:2
相关论文
共 50 条
[41]   Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer [J].
Kambiz Rahbar ;
Martin Bögeman ;
Anna Yordanova ;
Maria Eveslage ;
Michael Schäfers ;
Markus Essler ;
Hojjat Ahmadzadehfar .
European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 :243-246
[42]   Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function [J].
Rosar, Florian ;
Kochems, Niklas ;
Bartholomae, Mark ;
Maus, Stephan ;
Stemler, Tobias ;
Linxweiler, Johannes ;
Khreish, Fadi ;
Ezziddin, Samer .
CANCERS, 2021, 13 (12)
[43]   German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients [J].
Rahbar, Kambiz ;
Ahmadzadehfar, Hojjat ;
Kratochwil, Clemens ;
Haberkorn, Uwe ;
Schaefers, Michael ;
Essler, Markus ;
Baum, Richard P. ;
Kulkarni, Harshad R. ;
Schmidt, Matthias ;
Drzezga, Alexander ;
Bartenstein, Peter ;
Pfestroff, Andreas ;
Luster, Markus ;
Luetzen, Ulf ;
Marx, Marlies ;
Prasad, Vikas ;
Brenner, Winfried ;
Heinzel, Alexander ;
Mottaghy, Felix M. ;
Ruf, Juri ;
Meyer, Philipp Tobias ;
Heuschkel, Martin ;
Eveslage, Maria ;
Boegemann, Martin ;
Fendler, Wolfgang Peter ;
Krause, Bernd Joachim .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (01) :85-90
[44]   Effect of 177Lu-PSMA-617 radioligand therapy on quality of life in patients with advanced metastatic prostate cancer [J].
Scheer, C. ;
Juptner, M. ;
Zhao, Y. ;
Zuhayra, M. ;
Lutzen, U. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) :S130-S130
[45]   177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer [J].
Braeuer, Axel ;
Grubert, Lena Sophie ;
Roll, Wolfgang ;
Schrader, Andres Jan ;
Schaefers, Michael ;
Boegemann, Martin ;
Rahbar, Kambiz .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) :1663-1670
[46]   Hematological Toxicity in Mice after High Activity Injections of 177Lu-PSMA-617 [J].
Kristiansson, Amanda ;
Timmermand, Oskar Vilhelmsson ;
Altai, Mohamed ;
Strand, Joanna ;
Strand, Sven-Erik ;
Akerstrom, Bo ;
Orbom, Anders .
PHARMACEUTICS, 2022, 14 (04)
[47]   Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617 [J].
Ferdinandus, Justin ;
Eppard, Elisabeth ;
Gaertner, Florian C. ;
Kuerpig, Stefan ;
Fimmers, Rolf ;
Yordanova, Anna ;
Hauser, Stefan ;
Feldmann, Georg ;
Essler, Markus ;
Ahmadzadehfar, Hojjat .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) :312-319
[48]   Dosimetry and External Radiation Exposure in 177Lu-PSMA-617 Radioligand Therapy. The INT Pascale Experience [J].
D'Ambrosio, L. ;
Palmese, V. Pirozzi ;
Maisto, C. ;
de Marino, R. ;
Aurilio, M. ;
Morisco, A. ;
Porfidia, V. ;
Traino, C. ;
De Migno, R. ;
Raddi, M. ;
De lauro, F. ;
Di Gennaro, F. ;
Lastoria, S. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) :S741-S742
[49]   177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer [J].
Axel Bräuer ;
Lena Sophie Grubert ;
Wolfgang Roll ;
Andres Jan Schrader ;
Michael Schäfers ;
Martin Bögemann ;
Kambiz Rahbar .
European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 :1663-1670
[50]   Relevant tumor sink effect in prostate cancer patients receiving 177Lu-PSMA-617 radioligand therapy [J].
Filss, Christian ;
Heinzel, Alexander ;
Mueller, Berthold ;
Vogg, Andreas T. J. ;
Langen, Karl-Josef ;
Mottaghy, Felix M. .
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2018, 57 (01) :19-25